Federated Learning with Differential Privacy for Ultrasound Breast Cancer Classification: An Empirical Study

Journal of Imaging, 2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.3390/jimaging12050205
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Breast cancer is a critical global health challenge, and deep learning shows transformative potential for medical image classification. However, privacy regulations such as HIPAA and GDPR create barriers to centralized data aggregation across institutions. This paper presents an empirical evaluation of federated learning (FL) for breast cancer classification in ultrasound images, systematically comparing seven deep learning architectures (ResNet-50, VGG16, VGG19, DenseNet-121, MobileNetV2, Vision Transformer, CoAtNet) across three FL algorithms (FedAvg, FedProx, FedOpt) with client-side differential privacy (DP). Using a simulated federation of eight institutions, we evaluate three clinically relevant classification scenarios. Federated models achieve performance comparable to centralized baselines-98.52% accuracy for normal/abnormal screening, 89.53% for three-class classification-with ViT-small and DenseNet-121 exceeding their centralized counterparts in several configurations. Under strong DP constraints (noise multiplier η=2.0, yielding conservative privacy budget estimates of ε<1.0 with δ=10-5), screening accuracy remains above 82%, though diagnostic tasks incur substantial degradation (best 68.42%). Our findings provide empirical guidance on architecture selection, FL algorithm choice, and privacy-utility trade-offs for privacy-preserving breast cancer diagnosis, while identifying key challenges for clinical deployment.